Granzyme M (Lymphocyte Met-Ase 1) (GZMM) Peptide
-
- Target See all GZMM products
- GZMM (Granzyme M (Lymphocyte Met-Ase 1) (GZMM))
- Origin
- Human, Mouse, Rat
- Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Characteristics
- The peptide is used to block Anti-Granzyme M Antibody reactivity.
-
- Application Notes
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
- Storage Comment
- Shipped at 4°C. Store at -20°C for one year.
- Expiry Date
- 12 months
-
- Target
- GZMM (Granzyme M (Lymphocyte Met-Ase 1) (GZMM))
- Synonyms
- LMET1 Peptide, MET1 Peptide, Lmet1 Peptide, MMET-1 Peptide, granzyme M Peptide, granzyme M (lymphocyte met-ase 1) Peptide, LOC100136381 Peptide, GZMM Peptide, Gzmm Peptide
- Background
- MET1, Granzyme M, Met-1 serine protease, Hu-Met-1, Met-ase, Natural killer cell granular protease
- Gene ID
- 3004
- UniProt
- P51124, Q03238
-